Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.16 USD | -5.26% |
|
+25.58% | -85.33% |
04:27pm | Goldman Sachs Adjusts Price Target on Amylyx Pharmaceuticals to $4 From $3, Maintains Neutral Rating | MT |
Jul. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.33% | 155M | |
+6.96% | 98.81B | |
+8.29% | 42.32B | |
-11.09% | 34.48B | |
+82.32% | 29.83B | |
-11.82% | 15.93B | |
+1.39% | 14.01B | |
-12.13% | 11.52B | |
+176.65% | 10.45B | |
+6.74% | 9.06B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Transcript : Amylyx Pharmaceuticals, Inc. - Special Call